6 result(s) for favipiravir
Japanese Companies Key To Hungary Economic Growth, Says FM
- 8 Jan 2021 8:00 AM
- hungarymatters.hu
- business
Japanese companies play a key role in Hungary’s economic growth, with 19 Japanese companies having invested 21 billion forints (EUR 58.5), creating over 13,000 jobs since the start of the coronavirus pandemic, Foreign Minister Péter Szijjártó said on Facebook, noting he had met Japanese Ambassador Masato Ohtaka for an introductory meeting.
Egis Favipiravir Drug Licenced For Covid-19 Treatment
- 21 Dec 2020 10:01 AM
- hungarymatters.hu
- health & wellness
A new drug with the active ingredient favipiravir manufactured by Hungarian pharmaceutical company Egis has been licenced for treatment of Covid-19 by the National Institute of Pharmacy and Nutrition (OGYÉI), the institute said on Saturday.
Covid Drug Favipiravir Arrives In Hungary From China, More Expected From Japan
- 11 Nov 2020 11:36 AM
- hungarymatters.hu
- health & wellness
Hungary received one million doses of Favipiravir last weekend from China, while the same amount of the Covid-19 drug is expected to arrive from Japan on Saturday, Cecília Müller, the country’s chief medical officer, said.
Coronavirus: Treatment Arrives From China
- 10 Nov 2020 8:20 AM
- http://www.hatc.hu
- health & wellness
Another one million favipiravir pills for treating Covid-19 patients have arrived from China, Foreign Minister Péter Szijjártó announced online yesterday.
First Hungarian Patients Receive Domestically Produced Remdesivir
- 14 Oct 2020 7:47 AM
- hungarymatters.hu
- health & wellness
The first few Hungarian patients have received doses of the domestically manufactured Covid-19 drug Remdesivir at the clinic of Debrecen University, the university’s press office said.
Manufacture Of Covid Drug Remdesivir Under Way In Hungary
- 12 Oct 2020 7:54 AM
- hungarymatters.hu
- health & wellness
Domestic manufacture of the Covid-19 drug Remdesivir is under way in Hungary, with pharmaceutical company Richter having manufactured enough clinical trial doses in the initial phase to treat some 250 patients, the innovation and technology ministry said.
Japanese Companies Key To Hungary Economic Growth, Says FM
- 8 Jan 2021 8:00 AM
- hungarymatters.hu
- business
Japanese companies play a key role in Hungary’s economic growth, with 19 Japanese companies having invested 21 billion forints (EUR 58.5), creating over 13,000 jobs since the start of the coronavirus pandemic, Foreign Minister Péter Szijjártó said on Facebook, noting he had met Japanese Ambassador Masato Ohtaka for an introductory meeting.
Egis Favipiravir Drug Licenced For Covid-19 Treatment
- 21 Dec 2020 10:01 AM
- hungarymatters.hu
- health & wellness
A new drug with the active ingredient favipiravir manufactured by Hungarian pharmaceutical company Egis has been licenced for treatment of Covid-19 by the National Institute of Pharmacy and Nutrition (OGYÉI), the institute said on Saturday.
Covid Drug Favipiravir Arrives In Hungary From China, More Expected From Japan
- 11 Nov 2020 11:36 AM
- hungarymatters.hu
- health & wellness
Hungary received one million doses of Favipiravir last weekend from China, while the same amount of the Covid-19 drug is expected to arrive from Japan on Saturday, Cecília Müller, the country’s chief medical officer, said.
Coronavirus: Treatment Arrives From China
- 10 Nov 2020 8:20 AM
- http://www.hatc.hu
- health & wellness
Another one million favipiravir pills for treating Covid-19 patients have arrived from China, Foreign Minister Péter Szijjártó announced online yesterday.
First Hungarian Patients Receive Domestically Produced Remdesivir
- 14 Oct 2020 7:47 AM
- hungarymatters.hu
- health & wellness
The first few Hungarian patients have received doses of the domestically manufactured Covid-19 drug Remdesivir at the clinic of Debrecen University, the university’s press office said.
Manufacture Of Covid Drug Remdesivir Under Way In Hungary
- 12 Oct 2020 7:54 AM
- hungarymatters.hu
- health & wellness
Domestic manufacture of the Covid-19 drug Remdesivir is under way in Hungary, with pharmaceutical company Richter having manufactured enough clinical trial doses in the initial phase to treat some 250 patients, the innovation and technology ministry said.














